In addition to p53 and RB alterations, recent WGS results of 35 HPV(+) HNSCC revealed for the first time that HPV genomic integration into certain important cellular genes, thus affecting their functions, may serve as additional mechanisms for HPV-medicated HNSCC oncogenesis. The gene discussed is RB1; the disease is head and neck squamous cell carcinoma.